Extremely Rapid Progression of Oral Cavity Carcinosarcoma

Case Report

Austin J Radiol 2023; 10(1) 1208.

Extremely Rapid Progression of Oral Cavity Carcinosarcoma

Berrada Kenza*, El Harass Yahya, Amalik Sanaa, Latib Rachida and Omor Youssef

National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.

*Corresponding author: Berrada Kenza National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.

Received: November 30, 2022; Accepted: January 03, 2022; Published: January 09, 2023

Abstract

Carcinosarcoma is a very rare malignant tumor of the salivary glands including accessory salivary gland, associating malignant mesenchymal and epithelial tissue. It usually occurs after 50 years of age. Its prognosis is very poor. We present a case of carcinosarcoma having evolved extremely rapidly.

Introduction

Carcinosarcoma is the only true malignant mixed tumor since it associates a malignant mesenchymal contingent with a malignant epithelial contingent [1]. It is a very rare tumor, whose prevalence among malignant tumors of the main salivary glands is 0.16 to 0.2% [1]. It develops in 70% of de novo cases and in 30% from a pre-existing pleomorphic adenoma. Its prognosis is very pejorative [2]. Carcinosarcoma can also develop from an accessory salivary gland [3]. The age of occurrence of this type of lesion is usually between 50 and 70 years [4]. We report the case of a 64-year-old man who had a carcinosarcoma whose rapid evolution did not allow optimal management

Case report

A 64-year-old man, with cerebral vascular arrest in 2015 and chronic smoking, presented to the maxillofacial service for lip swelling of rapid and brutal installation.

The history of the disease goes back 2 months from the diagnosis when the patient presented a palatine lesion rapidly increasing in volume, invading the upper right lip and reaching about 10cm, which motivated the patient to carry out several consultations on an outpatient basis.

The patient consulted the maxillofacial service where he benefited from a biopsy, the pathological analysis of this granuloma concluded to a chondrosarcoma. Immunomarkings showed P63, EMA, AML, h caldesmone, and vimentin expression (Figure 1).